Compositions and methods for obesity screening using polymorphisms in NPY2R

Details for Australian Patent Application No. 2005286944 (hide)

Owner Children's Medical Center Corporation Seracare Life Sciences, Inc.

Inventors Ardlie, Kristin; Hirschhorn, Joel; Campbell, Caterina deHaseth

Agent Pizzeys

Pub. Number AU-B-2005286944

PCT Pub. Number WO2006/034188

Priority 60/610,992 17.09.04 US

Filing date 19 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 23 June 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034188 Priority application(s): WO2006/034188

23 June 2011 Application Accepted

  Published as AU-B-2005286944

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286946-Purine derivatives and methods of use thereof

2005286943-Use of memantine (NAMENDA) to treat autism, compulsivity, and impulsivity